Innovation Pharmaceuticals Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Innovation Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $0.000.
  • Innovation Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Innovation Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Innovation Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jul 1, 2022 Jun 30, 2023 10-K 2023-09-28
2022 $0 $0 Jul 1, 2021 Jun 30, 2022 10-K 2023-09-28
2021 $0 $0 Jul 1, 2020 Jun 30, 2021 10-K 2022-09-28
2020 $0 $0 Jul 1, 2019 Jun 30, 2020 10-K 2021-09-27
2019 $0 Jul 1, 2018 Jun 30, 2019 10-K 2020-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.